Tyra Biosciences, Inc.
TYRA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001863127
In the last 90 days, Tyra Biosciences, Inc. insiders filed 1 open-market purchase and 0 sales; 168 institutions reported holding it in 13F filings for Q2 2026, worth $2.22B in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Tyra Biosciences, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 59 | 59 | 0 |
| Shares | 36.2M | 36.5M | +251.8K (+0.7%) |
| Value | $616.7M | $502.1M | −$114.6M (−18.6%) |
New holders (4)
Institutions that held Tyra Biosciences, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| 5AM Venture Management, LLC | 411,450 | $5.67M | 1.63% |
| Parkwood LLC | 16,967 | $234.0K | 0.04% |
| Susquehanna International Group, LLP | 11,872 | $163.5K | 0.00% |
| Corton Capital Inc. | 11,009 | $151.6K | 0.08% |
Sold out (4)
Institutions that held Tyra Biosciences, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Fishman Jay A Ltd | 22,000 | $374.7K |
| Millennium Management LLC | 21,591 | $367.7K |
| Boothbay Fund Management, LLC | 10,174 | $173.3K |
| Allspring Global Investments Holdings, LLC | 2,273 | $38.7K |